Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Sees Large Growth in Short Interest

Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCYGet Rating) was the target of a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 54,000 shares, a growth of 130.8% from the March 15th total of 23,400 shares. Based on an average trading volume of 117,300 shares, the days-to-cover ratio is currently 0.5 days.

CHGCY has been the topic of a number of recent research reports. Zacks Investment Research raised Chugai Pharmaceutical from a “hold” rating to a “buy” rating and set a $18.00 price objective on the stock in a research report on Wednesday, March 16th. The Goldman Sachs Group raised Chugai Pharmaceutical from a “neutral” rating to a “buy” rating in a research report on Thursday, January 13th.

Chugai Pharmaceutical stock opened at $16.89 on Thursday. Chugai Pharmaceutical has a twelve month low of $15.08 and a twelve month high of $21.30. The stock’s fifty day simple moving average is $16.71 and its 200-day simple moving average is $17.00.

About Chugai Pharmaceutical (Get Rating)

Chugai Pharmaceutical Co, Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan.

Featured Articles

Receive News & Ratings for Chugai Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chugai Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.